article thumbnail

CDMO to manufacture SARS-CoV-2 intranasal vaccine

European Pharmaceutical Review

The National Institutes of Health (NIH) has chosen contract development, and manufacturing organisation (CDMO) Exothera SA to develop the manufacturing process for its intranasal vaccine against SARS-CoV-2 coronavirus to treat COVID-19. MHRA authorises new COVID-19 vaccine What will the intranasal vaccine manufacturing project involve?

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

2,3 Clinical implementation of CAR T-cell technology requires a reproducible T-cell manufacturing platform, which necessitates effective gene-transfer tools and T-cell culture conditions. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The continued shame of pharma

World of DTC Marketing

Currently, federal law prohibits Medicare from negotiating drug prices directly with manufacturers. This would include drugs covered by both Medicare Part B (physician-administered drugs) and Part D (prescription medications). The secretary of the U.S.

Pharma 256
article thumbnail

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission

Legacy MEDSearch

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Inspira Technologies OXY B.H.N. and Israel.

article thumbnail

American healthcare is too profitable

World of DTC Marketing

healthcare system is bedeviled by greed, with drug companies, device manufacturers, hospital organizations, physician groups, and insurers scrambling to grab a slice of the more than $3 trillion we spend on medical care each year. (FT.COM) The U.S. We have access to the most cutting-edge treatments.

article thumbnail

“Game-changing” obesity drug over-promising?

World of DTC Marketing

” One has to wonder if physicians are warning patients that Wegovy is NOT a miracle cure for obesity but must be taken with a strict diet and increased exercise. Nearly 3% of the overall U.S. The reasons are complex. Many factors contribute to obesity. In that case, much of the surplus energy will be stored by the body as fat.”

Insurance 271
article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

Patients trust their doctors, so the accelerated approval process must be modified to increase their trust with physicians and explain to patients precisely what accelerated drug approval means. Do patients care? The answer to that would be “no.” of approvals), cancer (35.6%), and other rare diseases (24.7%).

Patients 200